Johnson & Johnson recently launched the Dr. Paul Janssen Project –a multi-faceted public engagement initiative that extends the legacy of Dr. Paul Janssen – one of the most accomplished industry researchers and humanitarians of the 20th century – and promotes broader engagement and appreciation for the value that science and technology innovation brings to humanity.
The Project encompasses programs that fuel the next generation of innovators, celebrate the power of science to change the world and inspire champions of science across the globe.
“Today, more than ever, science needs champions who can engage society in a broader way,” said Seema Kumar, Vice President, Innovation, Global Health and Science Policy Communication, Johnson & Johnson. “As a global healthcare company, we have an opportunity and a responsibility to influence the popular culture narrative about the role of science in society, and engage people of all generations and backgrounds to see the unlimited opportunities that science brings in the future of health.”
As one of the first initiatives of The Project, Johnson & Johnson will host a series of Champions of Science, "What's New?" QuickFire Challenges. The first Challenge, titled "The Lab Coat of the Future", will be judged by Daymond John, world renowned entrepreneur and Shark on ABC's four-time Emmy Award winning series, Shark Tank.
The company also launched, in collaboration with Scientific American Custom Media, a new content series to share the stories of brilliant thinkers, big ideas and exciting breakthroughs that make our world a better place.
Earlier this year, the Johnson & Johnson launched the #ChampionsofScience campaign to encourage social media users to share their support of science with the world. The company committed to donating $5 for each use of the hashtag through September 30, 2017 up to a total donation of $50,000, to the Biotechnology Institute. The campaign has already exceeded its goal, with a total of more than 22,500 hashtag uses to date.
The Dr. Paul Project was officially announced at the 2017 Dr. Paul Janssen Award for Biomedical Research events, which honored the 2017 Award winner, Dr. Douglas Wallace of the of the Children’s Hospital of Philadelphia. Dr. Wallace was selected as this year’s honoree for his pioneering work in the field of Mitochondrial disease.
Recent celebrations honoring Dr. Wallace’s illustrious 47-year career in Mitochondrial genetics took place in New York and Beerse, Belgium—the home of Dr. Paul. See event highlights here.
“Dr. Paul put patients at the heart of everything he did, often challenging scientific dogma, in order to to develop life-saving and life-changing treatments.We are fortunate to have champions of science who have come before us, like Dr. Paul, and who walk among us today, like Dr. Wallace, whose scientific curiosity and committment to improving human health will have a lasting impact on our world,” said Dr. Paul Stoffels, Chief Scientific Officer, Johnson & Johnson.
To learn more about the Dr. Paul Project Champions of Science:
- Visit the web site www.drpaulproject.com
- Read more from Paul Stoffels about why true innovators are rebels.
- Read more from Seema Kumar about the real Champions of Science.
- Hear from mom and champion of science Meredith Hardy about her family’s journey with mitochondrial disease and how the work of 2017 Dr. Paul Janssen Award winner impacted her life.